Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DB25FD4XA
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,715
Award facts
- Contract value 100% obligated
- $22,714.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $22,714.80 by the Defense Logistics Agency on August 13, 2025, with an ultimate completion date of August 14, 2025. This delivery order is for NUCALA 100 mg/ml auto-injector medication and was issued without a set-aside designation. The award represents a single delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, a $499.9 million master contract valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies.
As a primary pharmaceutical supplier to the Department of Defense healthcare system, DMS Pharmaceutical Group has demonstrated consistent success in securing federal contracts for specialized pharmaceutical products, including biologics, auto-injectors, and prescription medications supporting military health facilities nationwide. The company's positioning within DLA's pharmaceutical supply chain reflects its established capability to deliver critical medications and medical consumables directly to DoD healthcare sites. This delivery order for NUCALA auto-injectors contributes to the agency's broader objective of maintaining adequate pharmaceutical inventory for military personnel and beneficiaries across federal medical treatment facilities.
Quick answers
Who was awarded contract SPE2DB25FD4XA?
SPE2DB25FD4XA was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 13, 2025.
How much is contract SPE2DB25FD4XA worth?
The government has obligated $22,715 on SPE2DB25FD4XA.
Is contract SPE2DB25FD4XA an order under another contract?
Yes. SPE2DB25FD4XA is a delivery order under SPE2DB20D9214, an indefinite delivery contract.
Was contract SPE2DB25FD4XA competed?
The extent of competition for SPE2DB25FD4XA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award